Search clinical trials for: injection drug user (IDU) syringe customers

Total 264186 results

Fakultas Kedokteran Universitas Indonesia

Unknown

A Trial Comparing Pain During Local Tumesent Injection In Fingers Using Different Syringe-Needle Combinations

Pain | Anesthesia, Local | Injection Site | Infiltration

Indonesia
AbbVie (prior sponsor, Abbott)

Completed

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States
Eli Lilly and Company

Terminated

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Lupus Erythematosus, Systemic

Korea, Republic of, Puerto Rico, United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

Virus Diseases

Mali, Senegal
PharmaJet, Inc.

Completed

Jet Injection for Influenza (JIFI)

Influenza, Human

United States
Johns Hopkins University
American Thoracic Society

Completed

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

Tobacco Dependence

United States
National Cancer Institute (NCI)

Completed

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers

HIV Infections | Lung Cancer | Drug Addiction | AIDS | Tobacco Addiction

United States
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis (SARIL-RA-EASY)

RA

United States, Chile, Mexico, Poland, Russian Federation, South Africa
CytoDyn, Inc.

Withdrawn

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

HIV

United States
Centre hospitalier de l'Université de Montréal...
Fonds de la Recherche en Santé du Québec

Terminated

Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

Active or Ex-injection Drug Users | Indication of Hepatitis C Screening

Canada
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

Rheumatoid Arthritis

Japan
National Institute on Drug Abuse (NIDA)
University of Washington

Completed

Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users

Substance-Related Disorders | Hepatitis

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)

Hepatitis C Virus Infection

Canada
Hoffmann-La Roche

Completed

A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe

Healthy Volunteer

New Zealand
Tongji Hospital

Unknown

Parathyroid Auto-transplantation: Prospective Randomized Trial of the Personalized Site

Parathyroid Autologous Transplantation

China
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia (JAKPRO)

HIV Risk Behaviors | Heroin Injection | Retention in Methadone Treatment

Indonesia
The City College of New York
National Institute on Drug Abuse (NIDA); Johns Hopkins University

Completed

Neurobehavioral Model of HIV in Injection Drug Users

HIV Infections | Drug Abuse

United States
Novartis Pharmaceuticals

Terminated

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. (REASSURE2)

Rheumatoid Arthritis

United States, Germany, Greece, Argentina, Brazil, Colombia, Czech Republic, Dominican Republic, Guatemala, India, Italy, Japan, Korea, Republic of, Panama, Portugal, South Africa
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Indigenous Outreach Among Injection Drug Users to Treat and Control TB

Lung Diseases | Tuberculosis
University of New Mexico

Completed

Reciprocating Medical Devices - a Study of a New Safety Device (RPD)

Cancer | Osteoarthritis | Rheumatoid Arthritis | Trauma | Thyroid Nodule

United States
Butler Hospital
Boston Medical Center

Completed

Linking Hospitalized Injection Drug Users to Buprenorphine

Opiate Dependence

United States
University of Wisconsin, Madison

Completed

The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection

Influenza
King Abdulaziz University

Completed

Computer Controlled Local Anesthesia in Children (STA machine)

Pain Perception of the New Device | The Pain Related Behavior | The Effectiveness of Anesthesia

Saudi Arabia
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

Directly Observed Hepatitis C Treatment in Methadone Clinics

Hepatitis C | Medication Adherence

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

HCV Negative Status | HCV Risk Behavior

United States
AstraZeneca
Celerion

Completed

Autoinjector Device Assessment Study (BCB119)

Healthy Subjects

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin

HIV | Heroin Dependence | Cocaine-Related Disorders

United States
Rockefeller University

Completed

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Intravenous Drug Usage

United States
Biogen

Completed

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Multiple Sclerosis

United States
Pfizer

Completed

Users Study Of The Caverject Delivery System

Healthy

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

HIV | Opioid Dependence

United States
Green Cross Corporation

Completed

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Prevention of Influenza
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

Substance-Related Disorders | Depression | HIV Infections

United States
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users

Substance-Related Disorders | Depression | HIV Infections

United States
Sanofi

Completed

Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus (Pen Preference)

Diabetes Mellitus, Type 2

United States
State University of New York - Upstate Medical...

Completed

Improving Hepatitis C Treatment in Injection Drug Users

Liver Diseases | Alcoholism | Hepatitis C | Drug Abuse

United States
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA); Johns Hopkins University

Completed

A Network & Dyad HIV Prevention Intervention for IDU's - 1

Hepatitis | HIV

United States
Centers for Disease Control and Prevention
Health Services Resource Adminstration - HIV/AIDS Bureau

Completed

Behavioral Intervention Trial for HIV-infected Injection Drug Users

HIV

United States
Centers for Disease Control and Prevention

Completed

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

HIV Infections | Hepatitis C

United States
Calibra Medical, Inc.
Northwestern University; University of Texas Southwestern Medical Center; Henry... and other collaborators

Completed

Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

Diabetes Mellitus

United States
UCB Pharma

Completed

Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

Healthy

France
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method (T-jet®)

Growth Hormone Deficiency
National Cancer Institute (NCI)

Completed

Validation of Self-Reported Needle Sharing Among Injection Drug Users

Viral Infection

United States
Sheba Medical Center

Unknown

Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

Alopecia Areata

Israel
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts

HIV Infections

United States, Thailand
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV

Hepatitis C Virus Infection

Canada
Organization to Achieve Solutions in Substance...
Centers for Disease Control and Prevention

Completed

A Video-Based HCV Curriculum for Active Injection Drug Users

Hepatitis C | Opiate Dependence

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers

HIV Infections

United States
Pfizer

Completed

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Contraception | Bone Density

United States
Valeritas, Inc.

Terminated

Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device

Type 1 Diabetes | Type 2 Diabetes

United States

Search clinical trials for: injection drug user (IDU) syringe customers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations